Mast Therapeutics Inc (NYSE MKT LLC:MSTX)

0.485
Delayed Data
As of Mar 31
 -0.0125 / -2.51%
Today’s Change
0.40
Today|||52-Week Range
0.73
-13.39%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.75, with a high estimate of 3.00 and a low estimate of 1.00. The median estimate represents a +467.01% increase from the last price of 0.49.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.06
Sales
$0.00
Reporting Date
Mar 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.67%
 
 
 
 
 
 
Growthannually 20.00%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account